Time-dependent modulation of thioredoxin reductase activity might contribute to sulforaphane-mediated inhibition of NF-κB binding to DNA

Antioxidants and Redox Signaling

Volumn 7, Issue 11-12, 2005, Pages 1601-1611

  Heiss, Elke ^a,b   Gerhäuser, Clarissa ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SULFORAPHANE; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; ENZYME INHIBITION; ENZYME REGULATION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINITROCHLOROBENZENE; DNA; ENZYME INHIBITORS; GLUTATHIONE; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN BINDING; THIOCYANATES; THIOREDOXIN REDUCTASE (NADPH); TIME FACTORS;

ANIMALIA;

EID: 28844478899     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1601     Document Type: Article

References (54)

1. Aggarwal BB, Takada Y, Shishodia S, Gutierrez AM, Oommen OV, Ichikawa H, Baba Y, and Kumar A. Nuclear transcription factor NF-κB: role in biology and medicine. Indian J Exp Biol 42: 341-353, 2004.
2. Anderson MT, Staal FJ, Gitler C, Herzenberg LA, and Herzenberg LA. Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc Natl Acad Sci U S A 91: 11527-11531, 1994.
3. Arner ES, Bjornstedt M, and Holmgren A. 1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity. J Biol Chem 270: 3479-3482, 1995.
4. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 107: 241-246, 2001.
5. Becker K, Gromer S, Schirmer RH, and Muller S. Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem 267: 6118-6125, 2000.
6. Bowie AG and O'Neill LA. Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogen-activated protein kinase. J Immunol 165: 7180-7188, 2000.
7. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
8. Brennan P and O'Neill LA. Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1260: 167-175, 1995.
9. Brennan P and O'Neill LA. Inhibition of nuclear factor κB by direct modification in whole cells-mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem Pharmacol 55: 965-973, 1998.
10. Chen LF and Greene WC. Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol 5: 392-401, 2004.
11. Chou TC and Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55, 1984.
12. Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, and Talalay P. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci U S A 98: 3404-3409, 2001.
13. Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20: 1657-1666, 1999.
14. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 27: 922-935, 1999.
15. Heiss E, Herhaus C, Klimo K, Bartsch H, and Gerhauser C. Nuclear factor κB is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 276: 32008-32015, 2001.
16. Hill KE, McCollum GW, and Burk RF. Determination of thioredoxin reductase activity in rat liver supernatant. Anal Biochem 253: 123-125, 1997.
17. Hintze KJ, Keck AS, Finley JW, and Jeffery EH. Induction of hepatic thioredoxin reductase activity by sulforaphane, both in Hepalclc7 cells and in male Fisher 344 rats. Nutr Biochem 14: 173-179, 2003.
18. Hintze KJ, Wald KA, Zeng H, Jeffery EH, and Finley JW. Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element. J Nutr 133: 2721-2727, 2003.
19. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-κB. J Biol Chem 274: 27891-27897, 1999.
20. Holmes-McNary M and Baldwin AS Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res 60: 3477-3483, 2000.
21. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, and Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13: 76-86, 1999.
22. Jeon KI, Jeong JY, and Jue DM. Thiol-reactive metal compounds inhibit NF-κB activation by blocking IκB kinase. J Immunol 164: 5981-5989, 2000.
23. Jeyapaul J and Jaiswal AK. Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of γ- glutamylcysteine synthetase heavy subunit gene. Biochem Pharmacol 59: 1433-1439, 2000.
24. Kim CH, Kim JH, Hsu CY, Ahn YS. Zinc is required in pyrrolidine dithiocarbamate inhibition of NF-κB activation. FEBS Lett 449: 28-32, 1999.
25. Kim W and Gates KS. Evidence for thiol-dependent production of oxygen radicals by 4-methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione (oltipraz) and 3H-1,2-dithiole-3-thione: possible relevance to the anticarcinogenic properties of 1,2-dithiole-3-thiones. Chem Res Toxicol 10: 296-301, 1997.
26. Matthews JR, Kaszubska W, Turcatti G, Wells TN, and Hay RT. Role of cysteine62 in DNA recognition by the p50 subunit of NF-κB. Nucleic Acids Res 21: 1727-1734, 1993.
27. Mitomo K, Nakayama K, Fujimoto K, Sun X, Seki S, and Yamamoto K. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-κB in vitro. Gene 145: 197-203, 1994.
28. Myzak MC, Karplus PA, Chung FL, and Dashwood RH. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 64: 5767-5774, 2004.
29. Nordberg J and Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31: 1287-1312, 2001.
30. Nordberg J, Zhong L, Holmgren A, and Arner ES. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J Biol Chem 213: 10835-10842, 1998.
31. Payen L, Courtois A, Loewert M, Guillouzo A, and Fardel O. Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane. Biochem Biophys Res Commun 282: 257-263, 2001.
32. Rundlöf AK and Arner ES. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events. Antioxid Redox Signal 6: 41-52, 2004.
33. Rundlöf AK, Carlsten M, and Arner ES. The core promoter of human thioredoxin reductase 1: cloning, transcriptional activity, and Oct-1, Sp1, and Sp3 binding reveal a housekeeping-type promoter for the AU-rich element-regulated gene. J Biol Chem 276: 30542-30551, 2001.
34. Rundlöf AK, Janard M, Miranda-Vizuete A, and Arner ES. Evidence for intriguingly complex transcription of human thioredoxin reductase 1. Free Radic Biol Med 36: 641-656, 2004.
35. Sakurai A, Yuasa K, Shoji Y, Himeno S, Tsujimoto M, Kunimoto M, Imura N, and Kara S. Overexpression of thioredoxin reductase 1 regulates NF-κB activation. J Cell Physiol 198: 22-30, 2004.
36. Sambrook J, Fritsch EF, and Maniatis T (Eds). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989, pp. 16.32-16.36.
37. Sambrook J, Fritsch EF, and Maniatis T (Eds). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989, pp. 16.66-16.67.
38. Sandalova T, Zhong L, Lindqvist Y, Holmgren A, and Schneider G. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc Natl Acad Sci U S A 98: 9533-9538, 2001.
39. Sen CK. Cellular thiols and redox-regulated signal transduction. Curr Top Cell Regul 36: 1-30, 2000.
40. Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK, Kamath R, Brown KD, Zhang L, and Baskaran R. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 279: 25813-25822, 2004. Epub 2004 Apr 8.
41. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
42. Tobi SE, Paul N, and McMillan TJ. Glutathione modulates the level of free radicals produced in UVA-irradiated cells. J Photochem Photobiol B 57: 102-112, 2000.
43. Wang D, Westerheide SD, Hanson JL, and Baldwin AS. Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 275: 32592-32597, 2000.
44. Wild AC and Mulcahy RT. Regulation of γ-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidant defenses. Free Radic Res 32: 281-301, 2000.
45. Yamamoto Y and Gaynor RB. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest 107: 135-142, 2001.
46. Yamane Y, Furuichi M, Song R, Van NT, Mulcahy RT, Ishikawa T, and Au KM. Expression of multidrug resistance protein/GS-X pump and γ- glutamylcysteine synthetase genes is regulated by oxidative stress. J Biol Chem 273: 31075-31085, 1998.
47. Ye J, Ding M, Zhang X, Rojanasakul Y, and Shi X. On the role of hydroxyl radical and the effect of tetrandrine on nuclear factor-κB activation by phorbol 12-myristate 13-acetate. Ann Clin Lab Sci 30: 65-71, 2000.
48. Yin MJ, Yamamoto Y, and Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396: 77-80, 1998.
49. Yu R, Lei W, Mandlekar S, Weber MJ, Der CJ, Wu J, and Kong AT. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J Biol Chem 274: 27545-27552, 1999.
50. Zhang Y. Role of glutathione in the accumulation of anti-carcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis 21: 1175-1182, 2000.
51. Zhang Y. Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis 22: 425-431, 2001.
52. Zhang Y and Callaway EC. High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem J 364: 301-307, 2002.
53. Zhang Y and Talalay P. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Cancer Res 58: 4632-4639, 1998.
54. Zhong H, May MJ, Jimi E, and Ghosh S. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636, 2002.